eISSN: 2299-0054
ISSN: 1895-4588
Videosurgery and Other Miniinvasive Techniques
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2022
vol. 17
 
Share:
Share:
Neurosurgery
Meta-analysis

Percutaneous endoscopic versus minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative diseases: a meta-analysis

Yi-Fan Song
1
,
Hui Wang
2
,
Jian-Wei Zhang
2
,
Yi-Ming Li
2
,
You-Di Xue
2
,
Yu-Fei Fu
3
,
Jie Li
1, 2

  1. Graduate School, Bengbu Medical College, Bengbu, China
  2. Department of Orthopaedics, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, China
  3. Department of Radiology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, China
Videosurgery Miniinv 2022; 17 (4): 591–600
Online publish date: 2022/08/10
Article file
Get citation
 
PlumX metrics:
 

Introduction

Lumbar degenerative diseases (LDD), which include lumbar spinal stenosis, lumbar disc herniation, spondylolisthesis, and lumbar instability, are common causes of back and leg pain [13]. Transforaminal lumbar interbody fusion (TLIF) is commonly used for patients with LDD and the purposes of TLIF are to relieve the symptoms and improve the quality of life [46]. Nevertheless, the classical open TLIF is correlated with iatrogenic injury of the paraspinal muscle, resulting in intractable postoperative low back pain [7]. At present, minimally invasive TLIF (MIS-TLIF) is widely used to minimize the soft tissue injury and intraoperative blood loss [8]. MIS-TLIF has shown significantly less blood loss compared with open TLIF [9]. However, MIS-TLIF is usually restricted by a limited working space and it is challenging to visualize deep surgical fields through the tubular retractor [10].

To overcome MIS-TLIF shortcomings, percutaneous endoscopic TLIF (PE-TLIF) has been commonly used for patients with LDD [1113]. PE-TLIF makes possible a complete endoscopic discectomy, spinal canal and foramina decompression, and interbody fusion via the endoscopic and working portal [1417]. Although numerous earlier investigations explored the relative efficacies of PE-TLIF and MIS-TLIF in treating LDD [1118], most of these studies were retrospective in nature. Since multiple factors can sway the outcomes of a retrospective investigation, and introduce unintentional bias, a meta-analysis is recommended to extensively evaluate relevant literature, reduce bias risk, and enhance the overall statistical power of the collective study outcomes.

Aim

Herein, our goal was to compare the safety and clinical effectiveness of PE-TLIF and MIS-TLIF in treating LDD.

Material and methods

Study selection

Our research abided by the guidelines of the Preferred Reporting Items for Systematic reviews and Meta-Analyses [18], and is registered at https://inplasy.com/ (Number: INPLASY202220090).

We screened for relevant publications in scientific databases, namely, PubMed, Embase, Cochrane Library, Wanfang, VIP, and CINK from the date of database establishment to November 2021. Our search terminologies were as follows: ((Endoscopic Lumbar Interbody Fusion) OR (Endo-LIF)) AND ((Minimally Invasive Transforaminal Lumbar Interbody Fusion) OR (MIS-TLIF)).

The following criteria were used to select relevant articles for analysis:

  • Studies: comparing between PE-TLIF and MIS-TLIF;

  • Diseases: LDD;

  • Language: Unlimited.

Studies with the following criteria were eliminated from the analysis: (a) single-arm investigations; (b) non-human investigations; and (c) studies without an English title and/or abstract.

Data accumulation

Two separate authors screened eligible publications and collected baseline study data, namely, author, year of publication, country of publication, study format, and quality assessment; and patient data, namely, population size, age, gender, disk range, body mass index (BMI), and follow-up duration; and many treatment-related data. Disagreements were rectified through consultation with a third author.

Quality evaluation

Randomized controlled trials (RCTs) were evaluated using the Cochrane risk of bias tool for the potential bias in performance, attrition, detection, screening, reporting, and so on. Non-RCTs were analyzed via the 9-point Newcastle-Ottawa scale (NOS) for potential selection bias, namely, selection (4 points), comparability (2 points), and exposure (3 points), carrying either high (≥ 7), moderate (4–6), or low (< 4) risk of bias [19].

Endpoints

The endpoints of this meta-analysis included visual analog scale (VAS)-leg, VAS-back, Oswestry Disability Index (ODI), fusion rate, surgical duration, blood loss, complication rates, and postoperative hospitalization.

Statistical analysis

RevMan v5.3 and Stata 12.0 were employed in this study. Dichotomous variables were accumulated depending upon odds ratios (ORs) with 95% confidence intervals (CIs), while continuous variables are accumulated depending upon mean difference (MD) with 95% CIs. Heterogeneity was examined via I2 tests, with I2 > 50% representing marked heterogeneity. Random-effects models were used to analyze marked heterogeneity, while fixed-effects models were used to analyze marked homogeneity. Heterogeneity sources are analyzed through sensitivity assessment. Funnel plot and Egger test are employed for evaluating publication bias risks.

Results

Included studies

We initially found 323 relative studies by using the research strategy. After step-by-step selection, a total of 8 studies were eligible for analysis (Figure 1, Table I). Seven studies were retrospective [1218], and 1 study was prospective [11]. Seven studies were from China [11, 12, 1418], and 1 study was from South Korea [13].

Figure 1

Flowchart of this study

/f/fulltexts/WIITM/47618/WIITM-17-47618-g001_min.jpg
Table I

Baseline data of the included studies

First authorYearCountriesDesignNewcastle-Ottawa scale
Ao [11]2020ChinaProspective8
Dong [12]2019ChinaRetrospective8
Kim [13]2021South KoreaRetrospective7
Li [14]2020ChinaRetrospective8
Wen [15]2020ChinaRetrospective7
Xue [16]2021ChinaRetrospective7
Zhang [17]2021ChinaRetrospective8
Zhao [18]2021ChinaRetrospective7

In these 8 included studies, 229 patients underwent PE-TLIF and 258 patients underwent MIS-TLIF (Table II). The mean age, gender ratio, and mean BMI were comparable between PE-TLIF and MIS-TLIF groups in the analyzed studies. The NOS of these studies ranged between 7 and 8.

Table II

Patients’ details in each study

Authors [ref.]Disease typesDisk rangeGroupsNumber of patientsAge [years]M/FBMIFollow-up [months]
Ao [11]Degenerative spondylolisthesisL3-S1PE-TLIF3552.8016/1924.7312
MIS-TLIF4053.6822/1825.0812
Dong [12]Disc herniation, Spondylolisthesis, Spinal stenosisL3-S1PE-TLIF2858.317/1123.324
MIS-TLIF2554.89/1623.024
Kim [13]Degenerative/lytic spondylolisthesisL2-S1PE-TLIF3270.517/15Unknown27.2
MIS-TLIF5567.325/30Unknown31.5
Li [14]Disc herniation, Spondylolisthesis, Spinal stenosisL4-S1PE-TLIF2252.012/10Unknown14.9
MIS-TLIF3050.718/12Unknown14.7
Wen [15]Not given in detailL4-S1PE-TLIF2048.3313/7Unknown12–20 for all
MIS-TLIF2050.7711/9Unknown
Xue [16]Not given in detailL3-5PE-TLIF2046.311/9Unknown16.1
MIS-TLIF2048.412/8Unknown15.8
Zhang [17]Degenerative/isthmic spondylolisthesisL3-S1PE-TLIF3253.112/2025.512
MIS-TLIF3055.714/1624.912
Zhao [18]Not given in detailL3-S1PE-TLIF4056.9337/17Unknown24
MIS-TLIF3857.0120/18Unknown24

[i] BMI – body mass index, M – male, F – female, PE-TLIF – percutaneous endoscopic transforaminal lumbar interbody fusion, MIS-TLIF – minimally invasive transforaminal lumbar interbody fusion.

Improvement of VAS-leg

Six studies compared the VAS-leg before and after treatment [1114, 16, 17]. The pooled ΔVAS-leg values are comparable between the 2 groups (MD = –0.31; 95% CI = –0.95–0.33; p = 0.35, Figure 2 A). Significant heterogeneity is found for this endpoint (I2 = 98%). Sensitivity analysis suggests that removing individual studies has no impact on the detected heterogeneity. No obvious publication bias is observed (Egger test, p = 0.597).

Figure 2

Pooled results of: A – improvement of VAS-leg, B – improvement of VAS-back, C – improvement of ODI, D – postoperative analgesic, E – fusion rates, F – operation time, G – intra-operative fluoroscopic time, H – intra-operative blood loss, I – length of incision, J – complication rates, K – time to ambulation, L – hospital stay

/f/fulltexts/WIITM/47618/WIITM-17-47618-g002_min.jpg

Improvement of VAS-back

Six studies compared the VAS-back before and after treatment [1114, 16, 17]. The pooled ΔVAS-back value is significantly higher in the PE-TLIF group (MD = 1.62; 95% CI: 0.92–2.32; p < 0.00001, Figure 2 B). Significant heterogeneity is found for this endpoint (I2 = 98%). Sensitivity analysis suggests that removing individual studies has no impact on the detected heterogeneity. No obvious publication bias is observed (Egger test, p = 0.188).

Improvement of ODI

Six studies compared the ODI before and after treatment [1114, 16, 17]. The pooled ΔODI values are comparable between the 2 groups (MD = 3.82; 95% CI: –1.53–9.18; p = 0.16, Figure 2 C). Significant heterogeneity is found for this endpoint (I2 = 98%). Sensitivity analysis suggests that removing individual studies has no impact on the detected heterogeneity. No obvious publication bias is observed (Egger test, p = 0.074).

Postoperative analgesic

Two studies reported the dose of postoperative analgesic [11, 12]. The pooled dose of postoperative analgesic is comparable between the 2 groups (MD = –32.45; 95% CI: –82.74–17.83; p = 0.21, Figure 2 D). Significant heterogeneity is found for this endpoint (I2= 99%). Sensitivity analysis cannot be performed because there are only 2 studies. The funnel plot does not reveal any publication bias.

Fusion rates

Seven studies reported the fusion rates after treatment [1114, 1618]. The pooled fusion rates are comparable between the 2 groups (90.4% vs. 90.3%; p = 0.86, Figure 2 E). No significant heterogeneity is found for this endpoint (I2= 0%). No obvious publication bias is observed (Egger test, p = 0.797).

Operation time

All studies reported the operation time. The pooled operation time is significantly lower in the MIS-TLIF group than in the PE-TLIF group (MD = 22.41; 95% CI: 6.48–38.34; p = 0.006, Figure 2 F). Significant heterogeneity is found for this endpoint (I2= 95%). Sensitivity analysis suggests that removing individual studies has no impact on the detected heterogeneity. We observed marked publication bias (Egger test, p = 0.049).

Intra-operative fluoroscopic time

Two studies reported the intra-operative fluoroscopic time [12, 17]. The pooled intra-operative fluoroscopic time is significantly lower in the MIS-TLIF group than in the PE-TLIF group (MD = 14.18; 95% CI: 12.07–16.30; p < 0.00001, Figure 2 G). No significant heterogeneity is found for this endpoint (I2 = 0%). The funnel plot does not reveal any publication bias.

Intra-operative blood loss

Seven studies reported on the intra-operative blood loss [11, 12, 1418]. The pooled intra-operative blood loss is drastically lower in the PE-TLIF group than in the MIS-TLIF group (MD = –77.48; 95% CI: –127.05–27.92; p = 0.002, Figure 2 H). Significant heterogeneity is found for this endpoint (I2 = 99%). Sensitivity analysis suggests that removing individual studies has no impact on the detected heterogeneity. We observed marked publication bias (Egger test, p = 0.021).

Length of incision

Three studies reported the length of incision [1517]. The pooled length of incision is significantly lower in the PE-TLIF group than in the MIS-TLIF group (MD = –1.14; 95% CI: –1.74–0.55; p = 0.0002, Figure 2 I). Significant heterogeneity is found for this endpoint (I2 = 78%). The significant heterogeneity disappears (I2 = 0%) when removing Xue’s study [16]. No obvious publication bias is observed (Egger test, p = 0.683).

Complication rates

Six investigations reported the complication rates after treatment [11, 12, 1417]. The collective complication rates are similar between the 2 groups (5.9% vs. 7.0%; p = 0.60, Figure 2 J). No significant heterogeneity is found for this endpoint (I2 = 0%). No marked publication bias is observed (Egger test, p = 0.733).

Time to ambulation

Four studies reported the data of time to ambulation [12, 13, 15, 17]. The poled time to ambulation is significantly lower in the PE-TLIF group than in the MIS-TLIF group (MD = –0.40; 95% CI: –0.63–0.17; p = 0.0006, Figure 2 K). Significant heterogeneity is found for this endpoint (I2 = 75%). The significant heterogeneity disappears (I2 = 0%) when removing Kim’s study [13]. No marked publication bias is observed (Egger test, p = 0.665).

Hospital stay

Five studies reported the data of time to ambulation [11, 13, 14, 16, 17]. The poled hospital stay time is significantly lower in the PE-TLIF group than in the MIS-TLIF group (MD = –3.03; 95% CI: –4.77–1.29; p = 0.0007, Figure 2 L). Significant heterogeneity is found for this endpoint (I2 = 96%). Sensitivity analysis suggests that removing individual studies has no impact on the detected heterogeneity. No marked publication bias is observed (Egger test, p = 0.400).

Discussion

This meta-analysis compared the clinical efficacy between PE-TLIF and MIS-TLIF for patients with LDD. The purpose of PE-TLIF and MIS-TLIF treatments for LDD is relieving the pain and enhancing quality of life. All the included studies found that VAS-leg, VAS-back, and ODI could be significantly improved by both PE-TLIF and MIS-TLIF. Our meta-analysis reveals that the degree of improvement of VAS-leg and ODI is comparable between PE-TLIF and MIS-TLIF. Furthermore, the need for a postoperative analgesic is also comparable between the 2 groups. These findings may indicate that both PE-TLIF and MIS-TLIF can achieve appropriate clinical effectiveness in patients with LDD. However, the PE-TLIF may achieve a faster recovery of back pain than MIS-TLIF does. This finding may be attributed to the fact that PE-TLIF intervention is associated with reduced surgical trauma to surrounding soft and bone tissues, compared to the MIS-TLIF intervention [16].

Fusion rate is also an important endpoint in this meta-analysis. We found that the collective fusion rate of PE-TLIF is comparable to MIS-TLIF, at approximately 90%. Hence, both PE-TLIF and MIS-TLIF achieve suitable interbody fusion. However, Ao et al. [11] found that MIS-TLIF can achieve a significantly higher fusion rate than PE-TLIF. This finding may suggest inadequate bone graft and expandable cage application [10]. Nonetheless, the results from the retrospective study should be further proven by RCTs.

The pooled operation and intra-operative fluoroscopic time are both significantly higher in the PE-TLIF group. The curette-mediated endplate preparation in PE-TLIF took a considerable amount of time. Since it relies on instrument palpations, without direct vision, and with sequential endoscopic guidance, the endplate preparation required more time than MIS-TLIF [2022].

Even though PE-TLIF is usually time consuming, it can result in significantly less intra-operative blood loss and better post-operative recovery. These results may be attributed to the shorter length of incision during PE-TLIF.

This meta-analysis shows comparable pooled complication rates between the 2 groups. Furthermore, the pooled complication rates after PE-TLIF and MIS-TLIF are only 5.9% and 7.0%, respectively. These findings indicate that both PE-TLIF and MIS-TLIF are safe for patients with LDD. If some patients experience the severe complication that is an abscess, external drainage is an effective method to treat it [23].

A similar meta-analysis reported insights into unilateral bi-portal endoscopy (UBE) in the treatment of lumbar diseases [24]. The researchers found that UBE surgery could significantly relieve the VAS scores of leg and back [24]. However, that meta-analysis only included single-arm studies [24]. Therefore, we could not find results about the comparison of UBE with other techniques. Our meta-analysis contained 2 commonly used techniques, and this is an advantage over the previous meta-analysis.

Our meta-analysis faced certain limitations. First, our analysis did not include any RCT. Furthermore, the multiple types of diseases and different disk ranges also increase the risk of bias. Therefore, further RCTs should be conducted. Second, there was a lack of homogeneity in surgical interventions and number of channels, which may influence our results. Many endpoints in this meta-analysis demonstrate significant heterogeneity. Third, there is a lack of cost-effective analysis among the included studies. Fourth, all eligible investigations were based in Asia. Therefore, additional comprehensive, global studies are warranted once stent usage becomes more prevalent worldwide.

Conclusions

Both PE-TLIF and MIS-TLIF are safe and effective strategies for patients with LDD. When compared, although MIS-TLIF results in reduced surgical duration and intra-operative blood loss, rapid post-operative recovery can be achieved by PE-TLIF.

Acknowledgments

This work is supported by the Scientific Research Project of Jiangsu Health Commission, Grant/Award (grant number: H2019023) and Youth Innovation project of Xuzhou Health Commission (grant number: XWKYHT20210557).

Conflict of interest

The authors declare no conflict of interest.

References

1 

Aoki Y, Takahashi H, Nakajima A, et al. Prevalence of lumbar spondylolysis and spondylolisthesis in patients with degenerative spinal disease. Sci Rep 2020; 10: 6739.

2 

Zárate-Kalfópulos B, Reyes-Tarrago F, Navarro-Aceves LA, et al. Characteristics of spinopelvic sagittal alignment in lumbar degenerative disease. World Neurosurg 2019; 126: e417-21.

3 

Jermy JE, Copley PC, Poon MTC, et al. Does pre-operative multifidus morphology on MRI predict clinical outcomes in adults following surgical treatment for degenerative lumbar spine disease? A systematic review. Eur Spine J 2020; 29: 1318-27.

4 

Mobbs RJ, Phan K, Malham G, et al. Lumbar interbody fusion: techniques, indications and comparison of interbody fusion options including PLIF, TLIF, MI-TLIF, OLIF/ATP, LLIF and ALIF. J Spine Surg 2015; 1: 2-18.

5 

de Kunder SL, van Kuijk SMJ, Rijkers K, et al. Transforaminal lumbar interbody fusion (TLIF) versus posterior lumbar interbody fusion (PLIF) in lumbar spondylolisthesis: a systematic review and meta-analysis. Spine J 2017; 17: 1712-21.

6 

Uçar BY, Özcan Ç, Polat Ö, et al. Transforaminal lumbar interbody fusion for lumbar degenerative disease: patient selection and perspectives. Orthop Res Rev 2019; 11: 183-9.

7 

Sihvonen T, Herno A, Paljärvi L, et al. Local denervation atrophy of paraspinal muscles in postoperative failed back syndrome. Spine 1993; 18: 575-81.

8 

Foley KT, Lefkowitz MA. Advances in minimally invasive spine surgery. Clin Neurosurg 2002; 49: 499-517.

9 

Li A, Li X, Zhong Y. Is minimally invasive superior than open transforaminal lumbar interbody fusion for single-level degenerative lumbar diseases: a meta-analysis. J Orthop Surg Res 2018; 13: 241.

10 

Zhu L, Cai T, Shan Y, et al. Comparison of clinical outcomes and complications between percutaneous endoscopic and minimally invasive transforaminal lumbar interbody fusion for degenerative lumbar disease: a systematic review and meta-analysis. Pain Physician 2021; 24: 441-52.

11 

Ao S, Zheng W, Wu J, et al. Comparison of preliminary clinical outcomes between percutaneous endoscopic and minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative diseases in a tertiary hospital: Is percutaneous endoscopic procedure superior to MIS-TLIF? A prospective cohort study. Int J Surg 2020; 76: 136-43.

12 

Dong J, Yang Y, Chen Z, et al. Comparative study of microendoscope-assisted and conventional minimally invasive transforaminal lumbar interbody fusion for degenerative lumbar diseases. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2019; 33: 814-21.

13 

Kim JE, Yoo HS, Choi DJ, et al. Comparison of minimal invasive versus biportal endoscopic transforaminal lumbar interbody fusion for single-level lumbar disease. Clin Spine Surg 2021; 34: E64-71.

14 

Li Y, Dai Y, Wang B, et al. Full-endoscopic posterior lumbar interbody fusion via an interlaminar approach versus minimally invasive transforaminal lumbar interbody fusion: a preliminary retrospective study. World Neurosurg 2020; 144: e475-82.

15 

Wen J, Wang D, Zhang H, et al. Full endoscopic and expandable channel minimally invasive transforaminal lumbar interbody fusion in the treatment of single-segmental lumbar degenerative diseases. J Clin Orthop 2020; 23: 487-91.

16 

Xue YD, Diao WB, Ma C, Li J. Lumbar degenerative disease treated by percutaneous endoscopic transforaminal lumbar interbody fusion or minimally invasive surgery-transforaminal lumbar interbody fusion: a case-matched comparative study. J Orthop Surg Res 2021; 16: 696.

17 

Zhang H, Zhou C, Wang C, et al. Percutaneous endoscopic transforaminal lumbar interbody fusion: technique note and comparison of early outcomes with minimally invasive transforaminal lumbar interbody fusion for lumbar spondylolisthesis. Int J Gen Med 2021; 14: 549-58.

18 

Zhao XB, Ma HJ, Geng B, et al. Early clinical evaluation of percutaneous full-endoscopic transforaminal lumbar interbody fusion with pedicle screw insertion for treating degenerative lumbar spinal stenosis. Orthop Surg 2021; 13: 328-37.

19 

Cook DA, Reed DA. Appraising the quality of medical education research methods: the Medical Education Research Study Quality Instrument and the Newcastle-Ottawa Scale-Education. Acad Med 2015; 90: 1067-76.

20 

Ahn Y, Youn MS, Heo DH. Endoscopic transforaminal lumbar interbody fusion: a comprehensive review. Exp Rev Med Devices 2019; 16: 373-80.

21 

Kolcun JPG, Brusko GD, Wang MY. Endoscopic transforaminal lumbar interbody fusion without general anesthesia: technical innovations and outcomes. Ann Transl Med 2019; 7 (Suppl 5): S167.

22 

Heo DH, Son SK, Eum JH, et al. Fully endoscopic lumbar interbody fusion using a percutaneous unilateral biportal endoscopic technique: technical note and preliminary clinical results. Neurosurg Focus 2017; 43: E8.

23 

Quanping X, Niu H, Li S. Preliminary clinical study: percutaneous lumbar discectomy combined with external drainage for treatment of intervertebral disc infections with epidural abscess. Videosurgery Miniinv 2020; 15: 625-31.

24 

Xie X, Zhang G, Liu N. Clinical effect of unilateral biportal endoscopy in the treatment of lumbar diseases: a systematic review and meta-analysis. Videosurgery Miniinv 2022; 17: 61-8.

Copyright: © 2022 Fundacja Videochirurgii This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
  
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.